Loading company…
SpyGlass Pharma develops treatments and drug delivery technology for eye diseases.
SpyGlass Pharma's drug delivery platform combines an intraocular lens with drug-eluting pads for use in cataract surgery. Founded in 2019, the company is based in Aliso Viejo, US. In February 2026, it raised USD 150 million in an IPO on Nasdaq under the ticker symbol SGP.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in